YOLFTbeta
Osteonic Co. Ltd

Osteonic Co. Ltd

226400 · KQ · Healthcare / Medical Devices

3,790.00KRW-60.00 (-1.56%)

Price History

Full chart

Market Stats

Previous Close3,850.00
Open3,890.00
Day Range3,760.00 – 3,920.00
52-Week Range3,710.00 – 7,740.00
Volume43.76K
Market Cap83.35B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.59
50-Day Avg4,411.60
200-Day Avg5,512.45

About

Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and biodegradable CMF plating systems under the BIOBSORB name. The company also provides products for trauma and extremities, which include hand plating, wrist plating, foot plating, and hallux valgus systems, as well as cannulated screws under the SIGNEX name. In addition, it offers dental products, such as mini screws, GBR systems, palatal plates, power drivers, and palatal expanders under the Optimus D name; veterinary systems; and sports medicines under the KINEX brand name. The company serves physicians and university hospitals. Osteonic Co., Ltd. was founded in 2012 and is based in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. DongWon Lee
  • Employees205
  • Headquarters1206Ho, 38, Digital-ro 29-gil, Seoul, South Korea, Korea
  • Websitehttps://www.osteonic.com

Leadership

  • Mr. DongWon LeeChief Executive Officer · b. 1969
  • Mr. Cheol-soo YoonSenior Executive Vice President · b. 1969
  • Mr. Chang-Ho MoonExecutive Director · b. 1970
  • Mr. Jeongnam ParkExecutive Director · b. 1971
  • Mr. Sangho SeoExecutive Director · b. 1974
  • Mr. Jun-gyu LeeExecutive Director · b. 1978
  • Mr. Dong-seon OhExecutive Director · b. 1971
  • Mr. JaeGeun ParkExecutive Director · b. 1968
  • Mr. Hyunjun ChoiExecutive Director · b. 1974
  • Mr. JungWoo ChaeExecutive Director · b. 1977

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.51B6.64B8.54B9.08B11.16B12.61B15.60B19.84B27.80B34.23B45.39B
Growth (%)-+89.33%+28.61%+6.37%+22.86%+13.02%+23.65%+27.19%+40.12%+23.15%+32.59%
Cost of Revenue1.34B2.64B3.67B5.17B6.13B7.12B9.10B11.11B14.75B17.49B23.33B
Gross Profit2.17B4.00B4.87B3.92B5.03B5.50B6.50B8.73B13.05B16.74B22.07B
Gross Margin61.75%60.20%56.97%43.11%45.06%43.56%41.68%44.01%46.95%48.90%48.61%
Operating Expense1.87B2.74B2.96B7.23B5.22B8.01B7.01B6.20B8.71B9.91B13.20B
Operating Income300.65M1.26B1.91B-3.31B-190.57M-2.51B-503.39M2.53B4.35B6.83B8.86B
Operating Margin8.57%18.94%22.33%-36.48%-1.71%-19.93%-3.23%12.73%15.63%19.95%19.53%
EBITDA-------5.87B5.24B11.03B13.29B
EBITDA Margin-------29.59%18.87%32.21%29.27%
Net Income468.26M1.54B-4.24B-6.64B498.68M-5.38B-2.85B835.53M3.66B5.65B7.50B
Net Income Margin13.35%23.20%-49.70%-73.05%4.47%-42.65%-18.28%4.21%13.16%16.50%16.52%
R&D119.00M240.75M513.47M218.06M202.78M149.65M255.78M454.15M1.25B1.56B3.91B
R&D as % of Total Revenue3.39%3.63%6.01%2.40%1.82%1.19%1.64%2.29%4.51%4.56%8.62%
Interest Expense000001.86B1.61B1.37B756.43M970.47M1.16B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%14.74%10.30%6.92%2.72%2.83%2.56%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-10.95B21.57B29.66B44.00B52.32B63.33B64.17B61.53B71.74B89.92B100.43B
Total Liabilities-4.61B9.89B22.23B15.50B23.36B39.05B28.64B25.02B19.86B30.60B32.85B
Total Equity-5.69B11.68B7.43B28.50B28.96B24.28B35.53B36.50B51.88B59.32B67.46B
Cash-1.68B1.74B3.70B10.00B5.36B9.95B12.94M12.29B4.13B9.99B14.44B
Total Debt-----12.01B11.42B-----
Net Debt-----11.51B13.69B3.74B-3.93B5.32B3.36B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.28B-1.73B-795.80M317.53M-2.46B2.75B2.95B3.99B4.14B4.72B9.02B
Investing Cash Flow-3.41B-3.63B-1.62B-11.59B-9.06B-10.10B-1.94B5.02B-13.18B-6.80B-
Financing Cash Flow6.20B5.41B4.64B17.52B6.85B12.07B-1.98B-6.46B827.14M7.75B-
Capital Expenditure1.17B3.20B1.10B5.26B5.95B949.15M939.46M481.34M6.97B7.05B8.95B
Free Cash Flow------526.14M-875.77M1.68B-2.83B-2.33B65.09M
FCF to OCF------19.12%-29.73%42.12%-68.42%-49.42%0.72%

Earnings

Report DateJun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------
EPS Actual25.6382.14-560.81-444.69-16.56-46.14-165.75-68.93-21.955.74121.89-22.84-276.50-27.59-95.82-186.52-112.95-4.4595.5315.4427.83-101.525.11-50.8116.5752.00165.262.0981.9462.76138.1738.2349.4299.13180.54130.3989.53
Surprise-------------------------------------
Timing-------------------------------------

Key Statistics & Ratios

Market Cap83.35B
Enterprise Value87.57B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.64
Price / Book1.11
Revenue (TTM)50.97B
Gross Profit (TTM)24.56B
EBITDA12.77B
Profit Margin20.02%
Operating Margin18.37%
Return on Equity15.23%
Return on Assets5.35%
Shares Outstanding20.06M
Shares Float14.75M
Beta0.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 24, 20203:2